Liver Health: Lepodisiran Study

We are studying how a single dose of Lepodisiran affects people with varying degrees of liver impairment and those with normal liver function. This research may help us understand the medication's safety and effectiveness in different liver conditions.

Safety phase (I)HepatologyInternal Medicine

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
CRU Hungary Kft.
Kistarcsa, Hungary
Sponsor: Eli Lilly & Co.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.